Camilla Frimor
How is second- and third-line treatment in Inflammatory Bowel Diseases used today, and is Therapeutic Drug Monitoring at least as effective, and potentially a more cost-efficient strategy when using these more expensive treatments?
Charlotte Nielsen Agergaard
Anaerobic bacteremia; Clinical presentation, treatment response and outcome.
Christian Huusmann Stampe Andersen
Diagnosis and outcome of patients with sepsis and disseminated intravascular coagulation (DIC) in the ICU.
Rikke Taudal Thorsen
Chronic use of opioids and clinical consequences in patients with major osteoporotic fractures.